Burlington, MA Network Drive, the 1.3 million s/f world-class office campus, has unveiled a new name, new logo and even a new address as part of an extensive rebranding exercise. The new name is Blue Sky Center. The change comes in response to a shift from predominantly office and computer technology tenants to a population that is comprised of lab and life science, and new age technology companies.

At present, over 270,000 s/f of construction and/or redevelopment for life science is under way at Blue Sky Center, and the campus has recently received entitlements from the town to expand by an additional 450,000 s/f.

“We are thrilled to continue the evolution of this unique asset into a new generation of innovation and real estate needs,” said Crosby Nordblom, senior vice president. “Initially constructed as Sun Microsystems’ corporate headquarters, the campus has since developed into a dynamic location able to meet the growing demands for infrastructure and amenities from a wide array of tenants. We look forward to elevating and expanding the campus further under the Blue Sky Center name.”

With a focus on sustainability and employee wellness, the campus features LEED Gold and ENERGY STAR certifications, and holds Fitwel Two-Star and WELL Health-Safety ratings.

Tenants have access to an ever-expanding list of on-site amenities including indoor and outdoor basketball courts, beehives, community herb and vegetable gardens, bocce, a putting green and golf simulator, fitness center, two café locations, billiards and ping pong tables, a pickle ball court and town hall amphitheater (coming soon), and more.

“Blue Sky Center has established itself as a benchmark offering for companies and their employees to thrive and collaborate. From software to hardware, life-science R&D to GMP production, the campus community is creating meaningful advancements across numerous fields. We are excited to watch the tenants at Blue Sky Center–soon to include Vericel Corp’s work in cell therapy and the Broad Institute’s extensive pursuits in genomic medicine–continue to push their individual frontiers,” said Patrick O’Neill, Vice President at Nordblom Company.